Monthly Archives: October 2010 - For Patients. By Patients - Stop Atrial Fibrillation

Canada Approves PRADAX (Dabigatran) for Atrial Fibrillation (Afib) Stroke Prevention

On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves …

Read More - For Patients. By Patients - Stop Atrial Fibrillation

Pradaxa (dabigatran) approved as alternative to warfarin for reducing atrial fibrillation stroke risk

The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa …

Read More - For Patients. By Patients - Stop Atrial Fibrillation

New Five Box Maze Procedure Is Promising Treatment for Persistent Atrial Fibrillation

A new mini maze procedure developed by Dr. John Sirak at Ohio State University is a promising new treatment for persistent atrial fibrillation as it closely replicates the "gold standard" Cox Maze III lesion set in the heart's left atrium. This “five box” thoracoscopic maze procedure may be better able to treat persistent AF specifically …

Read More